BT
AZN icon

Banque Transatlantique’s AstraZeneca AZN Stock Holding History

Banque Transatlantique’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9M Buy
63,714
+1,532
+2% +$288K 0.26% 50
2026
Q1 		$12.1M Buy
62,182
+61,981
+30,836% +$12M 0.29% 46
2025
Q4 		$37K Hold
201
– – ﹤0.01% 172
2025
Q3 		$30.8K Hold
201
– – ﹤0.01% 185
2025
Q2 		$28.2K Hold
201
– – ﹤0.01% 173
2025
Q1 		$29.5K Hold
201
– – ﹤0.01% 162
2024
Q4 		$26.2K Buy
+201
New +$28.1K ﹤0.01% 188

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Banque Transatlantique's AZN Position: Q2 2026 in Review

Banque Transatlantique increased its AstraZeneca (AZN) stake by 2.5% in Q2 2026, buying an estimated $288K and bringing the position to 63,714 shares worth $11.9M. The position accounts for 0.26% of the portfolio, ranked #50.

Banque Transatlantique first reported a position in AZN in Q4 2024 and has held it in 7 quarters since. The position peaked at $12.1M in Q1 2026. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Banque Transatlantique held 63,714 shares of AstraZeneca worth $11.9M as of Q2 2026.
  • Banque Transatlantique bought 1,532 AstraZeneca shares in Q2 2026, an estimated $288K.
  • AstraZeneca made up 0.26% of Banque Transatlantique's portfolio in Q2 2026, its #50 holding.
  • Banque Transatlantique first reported a position in AstraZeneca in Q4 2024 and has held it in 7 quarters since.
  • Banque Transatlantique's AstraZeneca position peaked at $12.1M in Q1 2026.
  • 1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Banque Transatlantique's 13F filing for Q2 2026, filed 30 Jul 2026.